Faculty profile

Kelsey McLaughlin

ResearcherObstetrics and GynecologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Kelsey McLaughlin

Researcher

Obstetrics and Gynecology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2025.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 4 research grants (4 CIHR), most recently in 2025.
Supervised 1 trainee who won CIHR awards, most recently in 2026.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Hypertension Placental Growth Factor Preeclampsia Pregnancy Outcomes Women'S Health Research Pregnancy Aspirin Preterm Preeclampsia

Latest papers

Mid-pregnancy circulating placental growth factor (PlGF) and obstetrical outcomes following nonovulatory and ovulatory frozen embryo transfer cycles.
Journal of assisted reproduction and genetics · 2025
Midpregnancy Placental Growth Factor Screening and Early Preterm Birth.
JAMA network open · 2024
Hypertensive Disorders and Cardiovascular Severe Maternal Morbidity in the US, 2015-2019.
JAMA network open · 2024

All 18 publications

Latest funding

Advancing preeclampsia care through the novel integration of non-invasive hemodynamic monitoring in a high-risk obstetric clinic
CIHR · 2026 · Supervisor
$27,000
The "predicting Short-term Adverse cadiovasculaR outcomes in preeclampsiA using BIomarkers" (SARABI) Study
CIHR · 2025 · Co-investigator
$1,319,625
ASpirin for Preeclampsia prevention for EveryoNe (ASPEN): a multicentre, double-blind, placebo-controlled, randomized noninferiority trial
CIHR · 2025 · Nominated PI
$100,000

All 8 grants and awards

18 publications.

Mid-pregnancy circulating placental growth factor (PlGF) and obstetrical outcomes following nonovulatory and ovulatory frozen embryo transfer cycles.

Dinh T, Sanchez Diaz N, McLaughlin K, Kingdom JC, Greenblatt EM, Drewlo S, Snelgrove JW

Journal of assisted reproduction and genetics2025

DOI: 10.1007/s10815-025-03605-3 PMID: 40750716

Midpregnancy Placental Growth Factor Screening and Early Preterm Birth.

Gladstone RA, Ahmed S, Huszti E, McLaughlin K, Snelgrove JW, Taher J, Hobson SR, Windrim RC, Murphy KE, Kingdom JC

JAMA network open2024

DOI: 10.1001/jamanetworkopen.2024.44454 PMID: 39541121

Hypertensive Disorders and Cardiovascular Severe Maternal Morbidity in the US, 2015-2019.

Malhamé I, Nerenberg K, McLaughlin K, Grandi SM, Daskalopoulou SS, Metcalfe A

JAMA network open2024

DOI: 10.1001/jamanetworkopen.2024.36478 PMID: 39361284

Maternal Placental Growth Factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy.

Snelgrove JW, Lee R, Jeyakumar Y, Greenblatt EM, Kingdom JC, Zwingerman R, McLaughlin K

Journal of assisted reproduction and genetics2024Senior author

DOI: 10.1007/s10815-024-03193-8 PMID: 39042339

Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study.

Zur RL, McLaughlin K, Aalto L, Jiang Y, Huszti E, Parks WT, Kingdom JC

BJOG : an international journal of obstetrics and gynaecology2024

DOI: 10.1111/1471-0528.17837 PMID: 38725333

Phenotype-Directed Management of Hypertension in Pregnancy.

McLaughlin K, Snelgrove JW, Sienas LE, Easterling TR, Kingdom JC, Albright CM

Journal of the American Heart Association2022First author

DOI: 10.1161/jaha.121.023694 PMID: 35285667

Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.

McLaughlin K, Hobson SR, Chandran AR, Agrawal S, Windrim RC, Parks WT, Bowman AW, Sovio U, Smith GC, Kingdom JC

American journal of obstetrics and gynecology2022First author

DOI: 10.1016/j.ajog.2021.08.027 PMID: 34461078

PlGF (Placental Growth Factor) Testing in Clinical Practice: Evidence From a Canadian Tertiary Maternity Referral Center.

McLaughlin K, Snelgrove JW, Audette MC, Syed A, Hobson SR, Windrim RC, Melamed N, Carmona S, Kingdom JC

Hypertension (Dallas, Tex. : 1979)2021First author

DOI: 10.1161/hypertensionaha.121.17047 PMID: 33840202

Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond.

Doherty A, McLaughlin K, Kingdom JC

Clinics in perinatology2020

DOI: 10.1016/j.clp.2020.05.014 PMID: 32713456

Low molecular weight heparin promotes transcription and release of placental growth factor from endothelial cells.

McLaughlin K, Nadeem L, Wat J, Baczyk D, Lye SJ, Kingdom JC

American journal of physiology. Heart and circulatory physiology2020First author

DOI: 10.1152/ajpheart.00109.2020 PMID: 32196359

Something wrong or missing on this profile? Suggest a correction

Kelsey McLaughlin

Research

Latest papers

Latest funding

Mid-pregnancy circulating placental growth factor (PlGF) and obstetrical outcomes following nonovulatory and ovulatory frozen embryo transfer cycles.

Midpregnancy Placental Growth Factor Screening and Early Preterm Birth.

Hypertensive Disorders and Cardiovascular Severe Maternal Morbidity in the US, 2015-2019.

Maternal Placental Growth Factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy.

Phenotypes of maternal vascular malperfusion placental pathology and adverse pregnancy outcomes: A retrospective cohort study.

Phenotype-Directed Management of Hypertension in Pregnancy.

Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.

PlGF (Placental Growth Factor) Testing in Clinical Practice: Evidence From a Canadian Tertiary Maternity Referral Center.

Hemodynamic Complications in Pregnancy: Preeclampsia and Beyond.

Low molecular weight heparin promotes transcription and release of placental growth factor from endothelial cells.

Advancing preeclampsia care through the novel integration of non-invasive hemodynamic monitoring in a high-risk obstetric clinic

The "predicting Short-term Adverse cadiovasculaR outcomes in preeclampsiA using BIomarkers" (SARABI) Study

ASpirin for Preeclampsia prevention for EveryoNe (ASPEN): a multicentre, double-blind, placebo-controlled, randomized noninferiority trial

Advancing the management of hypertension in pregnancy through Placental Growth Factor (PlGF) testing: A stakeholder-informed meeting to develop a national Canadian strategy and research agenda.

Redefining the diagnosis and treatment of hypertension in pregnancy through the integration of placental growth factor (PlGF) testing.

The "predicting Short-term Adverse cardiovasculaR outcomes in preeclampsiA using BIomarkers" (SARABI) Pilot Study

Healthy Mom, Healthy Heart: National Planning for the Evaluation of Knowledge & Cardiac Risk Assessment in Women with a History of Cardiovascular Complications During Pregnancy

Conscious Pregnancy: An Evidence-Based Website for Pregnant Women with Cardiovascular Disease

Frequent collaborators

Sascha Drewlo

Jennifer Taher

Michelle Hladunewich

Nir Melamed

Amy Metcalfe

Kara Nerenberg